Executive Medical Science Liaison
Celldex Therapeutics
Executive Medical Science Liaison
Celldex Therapeutics
Develops antibody-based therapies targeting inflammatory diseases
Celldex is pioneering new horizons in immunology to deliver life-changing therapies. We are relentless in our pursuit of novel antibody-based treatments that engage the human immune system and directly impact critical pathways in allergic, inflammatory, and autoimmune diseases.
We are building a world-class Medical Affairs organization to support late-stage development and launch for the company’s immunology asset. Our culture is entrepreneurial, fast-moving, and deeply mission-driven—where passionate individuals can make a meaningful impact.
Why Join Celldex?
The Executive Medical Science Liaison will prioritize contacts with key opinion leaders (KOLs), healthcare providers, and clinical investigators within an assigned U.S. region, providing advanced scientific exchange and generating actionable insights.
This role serves as a field-based extension of the Medical Affairs and Evidence Generation (MA&EG) organization, requiring a highly experienced professional who operates with independence, accountability, and execution focus in a fast-paced, performance-driven biotech environment.
The Associate Director is expected to deliver complex, data-driven scientific discussions, synthesize meaningful insights from the field, and navigate real-world clinical dynamics while maintaining a strong focus on regional ownership and high-impact engagement.
The role maintains and develops relationships across a range of stakeholders, including key opinion leaders, investigators, and as appropriate, large group practices and private equity-backed dermatology organizations, contributing to a broader understanding of evolving clinical and practice dynamics.
Enhancing knowledge / scientific exchange:
Insight gathering:
Regional ownership / execution:
Cross-functional engagement
Data generation/R&D SupportActs as a key scientific liaison between the organization and clinical investigators and study sites, supporting site identification, engagement, and scientific exchange.
Workstream leadership:
Experience elevation / team contribution:
Broader stakeholder engagement (as applicable):
Required Skills:
Education/Experience:
Develops antibody-based therapies targeting inflammatory diseases
Celldex Therapeutics develops antibody-based therapies for inflammatory, allergic, and autoimmune diseases, focusing on mast cell biology. Its lead program barzolvolimab is a humanized monoclonal antibody that inhibits KIT, reducing mast cell activity and inflammation; its pipeline includes other antibodies designed to engage the immune system or modulate disease pathways. The company leverages partnerships and licensing in addition to developing its own therapies to create a breadth of programs in its target areas. Its goal is to deliver therapies that lessen inflammation and autoimmune activity by targeting mast cells and related signaling pathways.
Explore more opportunities at Celldex Therapeutics